Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2006 3
2007 3
2008 2
2009 2
2010 1
2011 2
2012 2
2013 2
2014 8
2015 8
2016 3
2017 11
2018 10
2019 5
2020 3
2021 9
2022 14
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
Professor Mark Wainberg.
Benkirane M, Berkhout B, Borrow P, Fassati A, Fujii M, Garcia JV, Gorry P, Lever A, Mak J, Nijhuis M, Strebel K, Venter F, Weiss R. Benkirane M, et al. Among authors: venter f. Retrovirology. 2017 May 5;14(1):30. doi: 10.1186/s12977-017-0353-6. Retrovirology. 2017. PMID: 28476171 Free PMC article. No abstract available.
Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial.
Paton NI, Musaazi J, Kityo C, Walimbwa S, Hoppe A, Balyegisawa A, Asienzo J, Kaimal A, Mirembe G, Lugemwa A, Ategeka G, Borok M, Mugerwa H, Siika A, Odongpiny ELA, Castelnuovo B, Kiragga A, Kambugu A; NADIA Trial Team. Paton NI, et al. Lancet HIV. 2022 Jun;9(6):e381-e393. doi: 10.1016/S2352-3018(22)00092-3. Epub 2022 Apr 20. Lancet HIV. 2022. PMID: 35460601 Free article. Clinical Trial.
A trip down memory lane with Retrovirology.
Benkirane M, Berkhout B, Borrow P, Fassati A, Fujii M, Garcia-Martinez JV, Margolis D, Nijhuis M, Parent L, Strebel K, Venter F, Kirchhoff F, Lever A, Ross S, Mak J. Benkirane M, et al. Among authors: venter f. Retrovirology. 2019 Aug 21;16(1):22. doi: 10.1186/s12977-019-0485-y. Retrovirology. 2019. PMID: 31434571 Free PMC article. No abstract available.
Drug resistance and use of long-acting ART.
da Silva J, Siedner M, McCluskey S, Chandiwana N, Venter F, Raizes E. da Silva J, et al. Among authors: venter f. Lancet HIV. 2022 Jun;9(6):e374-e375. doi: 10.1016/S2352-3018(22)00059-5. Epub 2022 Mar 28. Lancet HIV. 2022. PMID: 35358419 No abstract available.
Diagnosis and Treatment of Listeria monocytogenes Endophthalmitis: A Systematic Review.
Chersich MF, Takkinen J, Charlier C, Leclercq A, Adams PE, Godbole G, Altmeyer U, Friesema IHM, Labbé Sandelin L, Jenkin L, Fontana L, Aldigeri R, Venter F, Luchters SMF, Lecuit M, Cimino L. Chersich MF, et al. Among authors: venter f. Ocul Immunol Inflamm. 2018;26(4):508-517. doi: 10.1080/09273948.2016.1276788. Epub 2017 Feb 1. Ocul Immunol Inflamm. 2018. PMID: 28145786 Review.
Prioritising the most needed paediatric antiretroviral formulations: the PADO4 list.
Penazzato M, Townsend CL, Rakhmanina N, Cheng Y, Archary M, Cressey TR, Kim MH, Musiime V, Turkova A, Ruel TD, Rabie H, Sugandhi N, Rojo P, Doherty M, Abrams EJ; PADO4 participants. Penazzato M, et al. Lancet HIV. 2019 Sep;6(9):e623-e631. doi: 10.1016/S2352-3018(19)30193-6. Lancet HIV. 2019. PMID: 31498110 Review.
Adult antiretroviral therapy guidelines 2017.
Meintjes G, Moorhouse MA, Carmona S, Davies N, Dlamini S, van Vuuren C, Manzini T, Mathe M, Moosa Y, Nash J, Nel J, Pakade Y, Woods J, Van Zyl G, Conradie F, Venter F. Meintjes G, et al. Among authors: venter f. South Afr J HIV Med. 2017 Jul 15;18(1):776. doi: 10.4102/sajhivmed.v18i1.776. eCollection 2017. South Afr J HIV Med. 2017. PMID: 29568644 Free PMC article.
100 results